ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 98 filers reported holding ENDOCYTE INC in Q2 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $18,000 | -14.3% | 1,000 | -33.3% | 0.01% | -14.3% |
| Q2 2018 | $21,000 | +50.0% | 1,500 | 0.0% | 0.01% | +40.0% |
| Q1 2018 | $14,000 | +133.3% | 1,500 | 0.0% | 0.01% | +150.0% |
| Q4 2017 | $6,000 | +200.0% | 1,500 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | -50.0% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $4,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | -20.0% | 1,500 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $5,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | +25.0% | 1,500 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $4,000 | -33.3% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $6,000 | -14.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $7,000 | -12.5% | 1,500 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $8,000 | -11.1% | 1,500 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $9,000 | 0.0% | 1,500 | 0.0% | 0.01% | -16.7% |
| Q4 2014 | $9,000 | 0.0% | 1,500 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $9,000 | +28.6% | 1,500 | +50.0% | 0.01% | +20.0% |
| Q2 2014 | $7,000 | -41.7% | 1,000 | +100.0% | 0.01% | -44.4% |
| Q1 2014 | $12,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |